Stock data

共信-KY (6617)

共信-KY is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$6.70M, up 32.6% from a year earlier. EPS over the last four quarters totals -NT$1.34.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 共信-KY in Insightr